Table 1.
Baseline Characteristics | IDV+EFV (n=143) (Arms 1+3) |
ABC+IDV+EFV (n=140) (Arms 2+4) |
TOTAL (n=283) (Arms 1-4) |
---|---|---|---|
Gender | |||
Men | 112 (78.3) | 111 (79.3) | 223 (78.8) |
Women | 31 (21.7) | 29 (20.7) | 60 (21.2) |
Race/Ethnicity | |||
White, non-Hispanic | 51 (35.7) | 54 (38.6) | 105 (37.1) |
Black, non-Hispanic | 60 (42) | 56 (40) | 116 (41) |
Hispanic (any race) | 30 (21) | 25 (17.9) | 55 (19.4) |
Asian, Pac. Isl. | 1 (0.7) | 4 (2.9) | 5 (1.8) |
Amer. Ind./Alask Nat. | 1 (0.7) | 1 (0.7) | 2 (0.7) |
Age | |||
mean | 40.3 | 39.1 | 39.7 |
std.dev. | 9.6 | 8.5 | 9.1 |
range | 21-74 | 21-67 | 21-74 |
IV Drug Use | |||
Never | 119 (83.2) | 108 (77.1) | 227 (80.2) |
Currently | 1 (0.7) | 2 (1.4) | 3 (1.1) |
Previously | 23 (16.1) | 30 (21.4) | 53 (18.7) |
Plasma HIV-1 RNAa (log10 copies/mL) |
|||
mean | 4.3 | 4.4 | 4.3 |
std. dev. | 0.8 | 0.7 | 0.7 |
range | 2.7 – 5.88 | 2.7 – 5.88 | 2.7 – 5.88 |
CD4 cell counta (cells/mm3) |
|||
mean | 125.5 | 141.2 | 133.3 |
std. dev. | 9.6 | 8.5 | 9.1 |
range | 0-723 | 0-420 | 0-723 |
Plasma HIV-1 RNA and CD4 values based on 142 subjects in the IDV+EFV group.